Cryoport, Inc. - Director's Dealing 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cryoport, Inc. (CYRX)
CIK: 0001124524
Period of Report: 2021-03-09

Reporting Person: Sawicki Mark W (Chief Scientific Officer)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-10	Common Stock	M	11342	$3.07	Acquired	30342	Direct
2021-03-10	Common Stock	M	7231	$1.87	Acquired	37573	Direct
2021-03-10	Common Stock	M	11831	$3.21	Acquired	49404	Direct
2021-03-10	Common Stock	S	3974	$54.6468	Disposed	45430	Direct
2021-03-10	Common Stock	S	9357	$55.3348	Disposed	36073	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-09	Option to purchase common stock	$58.94	A	21333	Acquired	2028-03-09	Common Stock (21333)	Direct
2021-03-09	Restricted Stock Rights	$	A	10667	Acquired		Common Stock (10667)	Direct
2021-03-10	Options to purchase common stock	$3.07	M	11342	Disposed	2025-08-20	Common Stock (11342)	Direct
2021-03-10	Options to purchase common stock	$3.21	M	11831	Disposed	2021-05-18	Common Stock (11831)	Direct
2021-03-10	Options to purchase common stock	$1.87	M	7231	Disposed	2026-05-06	Common Stock (7231)	Direct

F1: 1/48 of options vest on the 9th of each month for forty-eight months beginning 4/09/2021.

F2: Each restricted stock right represents a contingent right to receive one share of CYRX common stock.

F3: The restricted stock rights vest in four equal annual installments beginning 3/9/2022.

F4: 1/48th of the 77,625 options originally granted vested on the 7th of each month for forty-eight months beginning June 7, 2015.

F5: 1/48th of the 78,000 options originally granted vested on the 18th of each month for forty-eight months beginning June 18, 2017.

F6: 1/48th of the 70,000 options originally granted vested on the 6th of each month for forty-eight months beginning June 6, 2016.